ctrl K

Watchlist Price Alert

ZyVersa Therapeutics Inc. (ZVSA)

NASDAQ: ZVSA · Real-Time Price · USD

0.66

0.01 (2.29%)

At close: Jun 06, 2025, 1:52 PM

ZyVersa Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1.53M	3.14M	5.9M	328.58K	174.67K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	235.71K	98.48K	46.66K	286.66K	308.32K
Receivables	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	184.87K	215.46K	460.35K	483.2K	n/a
Total Current Assets	1.72M	3.35M	6.36M	811.78K	339.11K
Property-Plant & Equipment	n/a	14.77K	115.7K	27.73K	38.13K
Goodwill & Intangibles	18.65M	18.65M	111.98M	n/a	n/a
Total Long-Term Assets	18.88M	18.76M	112.14M	314.39K	346.46K
Total Assets	20.6M	22.11M	118.51M	1.13M	685.57K
Account Payables	9.34M	8.43M	6.03M	2M	2.31M
Deferred Revenue	n/a	n/a	n/a	765.68K	1.18M
Short-Term Debt	n/a	n/a	108.76K	9.15M	2.13M
Other Current Liabilities	854.7K	1.09M	1.36M	2.46M	2.18M
Total Current Liabilities	11.23M	10.19M	8.19M	13.63M	7.56M
Long-Term Debt	n/a	n/a	n/a	n/a	1.69M
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	851.66K	844.91K	10.32M	n/a	1.69M
Total Liabilities	12.08M	11.04M	18.51M	13.63M	9.24M
Total Debt	n/a	8.66K	108.76K	9.15M	3.82M
Common Stock	251.00	405.00	902.00	242.00	242.00
Retained Earnings	-112.63B	-103.22M	-4.92M	-52.9M	-44.81M
Comprehensive Income	n/a	n/a	n/a	-331.33K	-331.33K
Shareholders Equity	8.52B	11.07M	99.99M	-12.5M	-8.56M
Total Investments	1.53B	n/a	n/a	n/a	n/a